EUCOPE   

@EUCOPE

EUCOPE stands for innovative small to mid-sized companies active in and in Europe. Likes & RTs do not mean endorsement

Brussels/Belgium
Vrijeme pridruživanja: lipanj 2014.

Tweetovi

Blokirali ste korisnika/cu @EUCOPE

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EUCOPE

  1. 5. velj

    Hurry up! A few days left to submit your abstract for the largest patient-led rare disease event! 📢💪⬇️

    Poništi
  2. 4. velj

    Commissioner ' Cancer is persistent. But so is science.' 💪

    Poništi
  3. 4. velj

    . Pdt calling for more use of new technologies. 'AI can improve the precision of diagnosis'

    Poništi
  4. 4. velj

    MEPs Lucas Fourlas and opening speech: no patients should fight this alone.

    Poništi
  5. proslijedio/la je Tweet
    4. velj

    The 🧫 and 🧬 sector is booming. But the demand for is skyrocketing and the industry is struggling to meet it. What can we do? 👉

    Poništi
  6. proslijedio/la je Tweet
    31. sij

    UK withdrawal from the EU on 31 January 2020: During the transition period, EU pharmaceutical law will continue to be applicable to the UK, meaning that pharmaceutical companies can continue to carry out activities in the UK until the end of the year. 👉

    Poništi
  7. 30. sij

    How can the be implemented at the national and regional level to address current health systems challenges? On 4 February, join us, together with experts and partners from the coalition to explore solutions!

    Poništi
  8. 27. sij

    📢Call out to , academia and patient organisations! Do you want to bring your unique contribution to exciting projects on ? Register for the Networking Event in Paris on 03 March.

    Poništi
  9. proslijedio/la je Tweet
    23. sij

    📣Welcome to our new partners & SIHA! The Coalition now counts 3⃣3⃣ members…do you want to be the 34th & contribute to the next set to take place on 4/5 May in Brussels?📧info@euhealthcoalition.eu

    Poništi
  10. 23. sij

    Delighted to participate in DG Connect workshop on the testing facilities for AI in 🇪🇺! Bringing our members' expertise on the role of small & medium sized companies in deploying AI potential 💪🧮

    Poništi
  11. proslijedio/la je Tweet
    20. sij

    📢💰 have u applied 4t ? Do u have a on "Pre- to develop effective 4 "? Do u w 4⃣more from 4⃣different countries? Then do it 💪 deadline is 18 Feb!

    , , i još njih 7
    Poništi
  12. proslijedio/la je Tweet

    data is an essential resource for economic growth & innovation. The value of the European 🇪🇺 data economy may increase to €739 billion by 2020 🆙 (4% of the overall GDP). Discover what the EU 🇪🇺 is doing to build a common ➡️

    Poništi
  13. proslijedio/la je Tweet
    16. sij

    Submit a poster abstract for on one of 8 themes relating to rare diseases & orphan products by 10 Feb for the opportunity to showcase your research at 15-16 May in Stockholm.

    , , i još njih 7
    Poništi
  14. 14. sij

    Very interesting paper on the challenges of applying big data generation & management in the environment, and the need for further guidance.

    Poništi
  15. proslijedio/la je Tweet
    8. sij

    Alexander Natz, Secretary General will discuss "Pricing policies & guidelines" at our Annual Conference on , 5-6 March 2020, Brussels . Reduced registration fee before the 5th Feb.

    Poništi
  16. What to expect in EU health in the year ahead? See our take with other experts on exciting 12 months to come!

    , , i još njih 3
    Poništi
  17. proslijedio/la je Tweet

    🎶All wants for is ethics🎶 For Christmas and beyond we want AI that is: 1⃣ lawful 2⃣ ethical 3⃣ robust. Find out more about the AI ethics guidelines ➡️

    Poništi
  18. We need to look into solutions in terms of using new evidence generation, contracting models, etc. Things are happening. We can find solutions, says Secretary General Alexander Natz.

    Poništi
  19. We need more collaboration and communication between the and the HTA agencies, says Diane Kleinermans from 🇧🇪 Ministry of Health and Social Affairs.

    Poništi
  20. Interesting conclusions of the first study presented today: the regulation does not create monopolies. Competition is alive during and after market exclusivity.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·